more attention focused on urinary incontinence
You'll see more attention focused on urinary incontinence.
This is a big problem. More than 15 million people in North America suffer from bladder problems...only about 10% seek help.
The attention is partly fueled by interest in new extended-release versions of Ditropan (oxybutynin) and Detrol (tolterodine).